A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated hemoglobin levels

JAMA

Volumn 276, Issue 15, 1996, Pages 1246-1252

  Peters, Anne L ^a   Davidson, Mayer B ^b   Schriger, David L ^c   Hasselblad, Vic ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; EXERCISE; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 0029837937     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.15.1246     Document Type: Review

References (63)

1. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes. 1987;36:523-534
2. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815-819.
3. ADA position statement: office guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care. 1993; 16(suppl 2):4
4. Orchard TJ. From diagnosis and classification to complications and therapy. Diabetes Care. 1994;17: 326-338.
5. Melton LJ, Palumbo PJ, Chu C-P. Incidence of diabetes mellitus by clinical type. Diabetes Care. 1983; 6:75-86.
6. Knowler WC. Screening for NIDDM: opportunities for detection, treatment and prevention. Diabetes Care. 1994;17:445-450.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
8. Liu QZ, Petitt DJ, Hanson RL, et al. Glycated haemoglobin, plasma glucose and diabetic retinopathy. Diabetologia. 1993;36:428-432.
9. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1995;28:103-177.
10. Cederholm J, Ronquist G, Wibell L. Comparison of glycosylated hemoglobin with the oral glucose tolerance test a study in subjects with normoglycemia, glucose intolerance and non-insulin-dependent diabetes mellitus. Diabete Metab. 1984;10:224-229.
11. Albutt EC, Nattrass M, Northam BE. Glucose tolerance test and glycosylated haemoglobin measurement for diagnosis of diabetes mellitus: an assessment of the criteria of the WHO Expert Committee on Diabetes Mellitus 1980. Ann Clin Biochem. 1985;22:67-73.
12. Dods RF, Bolmey C. Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus. Clin Chem. 1979;25: 764-768.
13. 1c and the diagnosis of diabetes mellitus. Acta Med Scand. 1981;210:313-316.
14. Kesson CM, Youn RE, Talwar D, Whitelaw JW, Robb DA: Glycosylated hemoglobin in the diagnosis of non-insulin-dependent diabetes mellitus. Diabetes Care. 1982;5:395-398.
15. Lester E, Frazer AD, Shepherd CA, Woodroffe FJ. Glycosylated haemoglobin as an alternative to the glucose tolerance test for the diagnosis of diabetes mellitus. Ann Clin Biochem. 1985;22:74-78.
16. John WG, Richardson RW; Glycosylated haemoglobin levels in patients referred for oral glucose tolerance tests. Diabetic Med. 1986;3:46-48.
17. 1 and fructosamine in diagnosis of glucose-tolerance abnormalities. Diabetes Care. 1990;13:898-900.
18. 1c levels in a diabetes detection program. J Clin Endocrinol Metab. 1978;47:578-580.
19. Dix D, Cohen P, Kingsley S, Senkbeii J, Sexton K. Glycohemoglobin and glucose tolerance tests compared as indicators of borderline diabetes. Clin Cheria 1979;25:877-879.
20. Lev-Ran A, VanderLaan WP. Glycohemoglobins and glucose tolerance. JAMA 1979;241:912-914.
21. 1 in the diagnosis of chemical diabetes mellitus. Horm Metab Res. 1982;13:129-131.
22. 1c. Diabetes Res Clin Pract. 1987;3:343-349.
23. Mulkerin EC, Arnold JD, Dewar R, Sykes D, Rees A, Pathy MSJ. Glycosylated haemoglobin in the diagnosis of diabetes mellitus in elderly people. Age Ageing. 1992;21:175-177.
24. Ferrari E, Rossi L. Valutazione dei rapporti intercorrenti tra HbA1, HbA1c in soggestti con OGTT di tipo diabetico ed in soggetti normali. Quad Sclavo Diagn. 1985;21:126-129.
25. Seghieri G, De Giorgio LA, Gironi A, Innocenti F, Pettina G. Emoglobine glicosilate ed OGTT nella valutazione della tolleranze glicidica. Quad Sclavo Diagn. 1981;17:73-80.
26. 1c by a new liquid-chromatographic assay. Clin Chem. 1986;32:1867-1872.
27. Larsen ML. The utility of glycated hemoglobin in identification of impaired glucose tolerance. Diabetes Res. 1989;12:67-70.
28. Tsuji I, Nakamoto K, Hasegawa T, et al. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diabetes Care. 1991;14:1075-1077.
29. Sekikawa A, Tominaga M, Takahashi K, et al. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care. 1993; 16:570-574.
30. Hanson RL, Nelson RG, McCance DR, et al. Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med. 1993; 153:2133-2140.
31. 1c. and sensitivity to various degrees of glucose intolerance. Ann Intern Med. 1979;91:390-396.
32. 1c. Horm Metab Res. 1982;14:626-630.
33. Sekikawa A, Tominaga M, Takahashi K, Watanabe H, Miyazawa K, Sasaki H. Is examination of fructosamine levels valuable as a diagnostic test for diabetes mellitus? Diabetes Res Clin Proct. 1990;8: 187-192.
34. 1c-distribution in a healthy population: the Telecom Study. Diabetologia. 1989;32:864-869.
35. Simon D, Coignet MC, Thibult N, Senan C, Eschwege E. Comparison of glycosylated hemoglobin and fasting plasma glucose with two-hour post-load plasma glucose in the detection of diabetes mellitus. Am J Epidemiol. 1985;122:589-593.
36. Hall PM, John MS, Cook G, Sheldon J, Rutherford SM, Gould BJ. Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance. Diabetes Care. 1984;7:147-150.
37. Boucher BJ, Welch SG, Beer MS. Glycosylated haemoglobins in the diagnosis of diabetes mellitus and impaired glucose tolerance for the assessment of chronic hyperglycemia. Diabetologia. 1981;21:34-36.
38. Verillo A, De Teresa A, Golia R, Nunziata V. The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance. Diabetologia. 1983;24:391-393.
39. Forrest RD, Jackson CA, Yudkin JS. The glycohaemoglobin assay as a screen or screening test for diabetes mellitus: the Islington Diabetes Survey. Diabetes Med. 1987;4:254-259.
40. Modan M, Halkin H, Karasik A, Lusky A. Efetiveness of glycosylated hemoglobin, fastingplasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol. 1984;119:431-444.
41. Orchard TJ, Daneman D, Becker DJ, et al. Glycosylated hemoglobin: a screening test for diabetes mellitus? Preo Med. 1982;11:595-601.
42. Bolli G, Compagnucci P, Cartechini MG, et al. HbA1 in subjects with abnormal glucose tolerance but normal fasting plasma glucose. Diabetes. 1980; 29:272-277.
43. Motala AA, Omar MAK. The value of glycosylated haemoglobin as a substitute for the oral glucose tolerance test in the detection of impaired glucose tolerance (IGT). Diabetes Res Clin Pract. 1992;17:199-207.
44. WHO Expert Committee on Diabetes Mellitus. WHO Technical Report, Series 727. Geneva, Switzerland: World Health Organization; 1985.
45. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-1057.
46. Tustison WA, Bowen AJ, Cramptom JH. Clinical interpretation of plasma glucose values. Diabetes. 1966;15:775-777.
47. Ito C, Mito K, Hara H. Review of criteria for diagnosis of diabetes mellitus based on results of follow-up study. Diabetes. 1983;32:343-351.
48. Castro A, Scott JP, Grettie DP, Macfarlane D, Bailey RE. Plasma insulin and glucose responses of healthy subjects to varying glucose loads during three-hour glucose tolerance tests. Diabetes. 1970;19:842-851.
49. Chandalia HB, Boshell BR. Diagnosis of diabetes: the size and nature of the carbohydrate load. Diabetes. 1970;19:863-869.
50. Heages LV, Olkin I. Statistical Methods for Metaanalysis. Orlando, Fla: Academic Press; 1985:200-203.
51. Clark VA, Chapman JM, Coulson AH, Hasselblad V. Dividing the blood pressures from the Los Angeles Heart Study into two normal distributions. Johns Hopkins Med J. 1968:77-83.
52. McLaren CE, Brittenham GM, Hasselblad V. Statistical and graphical evaluation of erythrocyte volume distributions. Am J Physiol. 1987;252:H857-H866.
53. Hasselblad V. Estimation of parameters for a mixture of normal distributions. Technometrics. 1966; 8:431-441.
54. Hasselblad V. Estimation of finite mixtures of distributions from the exponential family. J Am Stat Assoc. 1969;64:1459-1571.
55. Olefsky JM, Reaven GM. Insulin and glucose responses to identical and oral glucose tolerance tests performed forty-eight hours apart. Diabetes. 1974; 23:449-453.
56. Kosaka K, Mizuno Y, Kuzuga T. Reproducibility of the oral glucose tolerance test and the rice-meal test in mild diabetes. Diabetes. 1966;5:901-904.
57. Wilkerson HLC, Butler FK, Francis JO'S. The effect of prior carbohydrate intake on the oral glucose tolerance test. Diabetes. 1960;9:386-391.
58. Rushforth NB, Miller M, Bennett PH. Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. Diabetologia. 1979;16:373-379.
59. Orchard TJ. From diagnosis and classification to complications and therapy. Diabetes Care. 1994;17: 326-338.
60. Melton LJ, Palumbo PJ, Chu C-P. Incidence of diabetes mellitus by clinical type. Diabetes Care. 1983; 6:75-86.
61. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995; 332:1251-1255.
62. McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308: 1323-1328.
63. Little RR, England JD, Wiedmeyer HM, et al. Relationship of glycosylated hemoglobin to oral glucose tolerance. Diabetes. 1988;37:60-64.